Revolutionizing Targeted Cancer Therapy

Our Focus

Welcome to MaveriX Oncology

MaveriX Oncology is exploiting new insights into cancer and immune cell metabolism to advance a new generation of Conditionally Activated Small Molecule TherapeuticsTM designed to specifically co-target cancer and the tumor immune microenvironment.

tumor immune microenvironment

Technology

The MaveriX IMPACT-2X Technology has the potential to revolutionize the targeted oncology space with safer and more efficacious therapeutics for the treatment of a broad range of solid tumors while challenging the limitations of current cancer immunotherapy.

Video by Nanobot Medical Animation Studio